Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 2, 2014
- Revision received April 2, 2015
- Accepted for publication April 6, 2015
- Published online November 6, 2015.
Copyright & Usage
© Copyright 2015 by the American Board of Family Medicine.
Author Information
- Steven-Huy Han, MD and
- Tram T. Tran, MD
- From the UCLA Medical Center, Pfleger Liver Institute, Los Angeles, CA (S-HH); and the Liver Disease and Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA (TTT).
- Corresponding author: Steven-Huy Han, MD, UCLA Medical Center, Pfleger Liver Institute, 200 UCLA Medical Plaza, Suite 214, Los Angeles, CA 90095 (E-mail: steven.han{at}ucla.edu).
In this issue
Jump to section
- Article
- Abstract
- Markers of HBV Infection and CHB Disease Progression
- HBV Screening
- Overview Management of CHB
- Special Considerations and Unresolved Issues in CHB Management
- Treatment Duration and Stopping Rules
- Role of Noninvasive Assessment of Liver Disease
- HCC Screening and the Role of HCC Risk Scores
- Directions for Future Research
- New Treatments for CHB
- Acknowledgments
- Notes
- References
- Figures & Data
- References
- Info & Metrics